Glaxo Smith Kline (BIOC.CA) Reports Year Ended 31/12/2019 Consolidated Results
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2019 To 31/12/2019
Net Profit : 142,635,872
F/S Consolidated Period : From 01/01/2018 To 31/12/2018
Net Comparative Profit : 49,928,030
Audit Status : Audited
Source : Glaxo Smith Kline
BOD Report (1,681 KB)
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2019 To 31/12/2019
Net Profit : 142,635,872
F/S Consolidated Period : From 01/01/2018 To 31/12/2018
Net Comparative Profit : 49,928,030
Audit Status : Audited
Source : Glaxo Smith Kline
BOD Report (1,681 KB)
Comments